In addition, we further performed a subgroup investigation and found the significantly higher expression of LAYN in the primary cancer patients than that of healthy controls in terms of age, gender, tumor grade, cancer stage, nodal metastasis status, and histological subtypes (Figures 3(a)–3(f)). Here, LAYN is linked to cancer.